EXPH5
protein-codingexophilin 5
Gene summary
The protein encoded by this gene is a member of the synaptotagmin-like protein (Slp) family lacking a C2 domain. It contains an N-terminal synaptotagmin-like homology domain (SHD), and is a ras-related protein Rab-27B effector protein. This protein is thought to be involved in exosome secretion and intracellular vesicle trafficking. Reduced expression of this gene results in keratin filament defects. Mutations in this gene have been associated with some cases of epidermolysis bullosa, an inherited skin fragility disorder. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~88.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014014
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014014
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014014
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014014
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014014
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Though appropriate skin care may be beneficial, it is unclear if early (genetic) diagnosis would be additionally advantageous
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EXPH5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015065.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 44 | 11 | 56 | ||
| missense | 280 | 42 | 21 | 343 | ||
| nonsense | 3 | 5 | 5 | 13 | ||
| start loss | 0 | |||||
| frameshift | 8 | 4 | 2 | 14 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 11 | 9 | 290 | 86 | 32 | 428 |
Highest pathogenic variant AF is 0.0000639049
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055880.2 | 6 | MANE Select | |
| Ensembl | ENSP00000265843.4 | 6 | MANE Select | |
| RefSeq | NP_001138235.1 | 5 | Standard | |
| RefSeq | NP_001138236.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer
Biological Process
- keratinocyte development
- intracellular protein transport
- positive regulation of exocytosis
- positive regulation of protein secretion
- multivesicular body sorting pathway
Molecular Function
- Rab GTPase binding
Cellular Component
- endosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000265843
- Coding exons
- 6
- Length
- 88308
- Individuals with no LoFs
- 125524
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 224
- Defined
- 125748
- p
- 0.000891
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.274 | 1025 | 1.00e+3 | 1.02 | 0.0000479 | 13092 |
| Missense (PolyPhen) | 195 | 222.63 | 0.87589 | 3194 | ||
| Synonymous | 0.605 | 361 | 376 | 0.960 | 0.0000194 | 3810 |
| Loss of Function | 1.93 | 49 | 65.9 | 0.743 | 0.00000349 | 906 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.0014 | 0.0012 | notable |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0011 | 0.0011 | notable |
| South Asian | 0.00067 | 0.00065 | rare |
| Other | 0.00084 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May act as Rab effector protein and play a role in vesicle trafficking.;
Recessive Scores
- pRec
- 0.0918
Intolerance Scores
- LoFtool
- 0.971
- RVIS EVS
- 4.12
- RVIS percentile EVS
- 99.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.661
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |